Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
United States
/
Healthcare
/
Progyny
PGNY
Progyny
Tightening US Healthcare Policies And Gig Shifts Will Dampen Prospects
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 8 Analysts
Published
08 May 25
Updated
16 Aug 25
0
Set Fair Value
0
votes
Share
AnalystLowTarget
's Fair Value
US$21.00
11.4% overvalued
intrinsic discount
16 Aug
US$23.40
Loading
1Y
11.2%
7D
2.4%
Author's Valuation
US$21.0
11.4% overvalued
intrinsic discount
AnalystLowTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystLowTarget Fair Value
US$21.0
11.4% overvalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
-13m
1b
2017
2019
2021
2023
2025
2027
2028
Revenue US$1.5b
Earnings US$88.2m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
8.25%
Healthcare Services revenue growth rate
0.27%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
6.78%
Calculation
US$88.21m
Earnings '28
x
21.45x
PE Ratio '28
=
US$1.89b
Market Cap '28
US$1.89b
Market Cap '28
/
74.29m
No. shares '28
=
US$25.47
Share Price '28
US$25.47
Share Price '28
Discounted to 2025 @ 6.78% p.a.
=
US$20.92
Fair Value '25
